I-Liraglutide CAS:204656-20-2 Umhlinzeki Womkhiqizi

I-Liraglutide uhlobo olusha lomuthi we-hypoglycemic ovuselela i-protein kinase esebenze yi-AMP ngaleyo ndlela ithuthukise ukuzwela kwe-insulin. Ayigcini nje ngokuba nomphumela obalulekile we-hypoglycemic, kodwa futhi inemisebenzi yokwehlisa isisindo, ukwehlisa umfutho wegazi, kanye nokuthuthukisa iphrofayili yamafutha egazini. I-Liraglutide, i-peptide-1 (GLP-1) receptor agonist yomuntu, yehlisa ukukhishwa kwesisu, yandisa ukusutha, futhi yehlisa ukudla kwesiguli, kuyilapho inciphisa isifiso sobuchopho sokudla futhi ivumela umzimba ukuthi usebenzise amandla amaningi. Ukwenyuka kokusetshenziswa kwamandla kudlala indima ekunciphiseni isisindo; kuvimbela isibindi ekukhiqizeni i-glucose eningi futhi kukhuthaza ama-pancreas ukuthi akhiqize i-insulin eningi ukuze kwehliswe ushukela wegazi; ngaphezu kwalokho, i-liraglutide nayo inezinzuzo zenhliziyo kanye nokuvikelwa kwezinso.